Question follow-through · 12371
Vorasidenib
To ask the Secretary of State for Health and Social Care, whether the MHRA is considering the approval of vorasidenib for the treatment of low grade gliomas.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 4 Nov 2024
- Target answer date
- 6 Nov 2024
- Answer
- 11 Nov 2024 · 7 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Dental Services: Romford · 5 Nov 2024
- Blood: Donors · 11 Nov 2024
- Obesity: Drugs · 13 Nov 2024
- NHS: Standards · 13 Nov 2024
- Prostate Cancer: Blood Tests · 19 Nov 2024
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
4 Nov 2024
Question tabled
To ask the Secretary of State for Health and Social Care, whether the MHRA is considering the approval of vorasidenib for the treatment of low grade gliomas.
6 Nov 2024
Target answer date
Date supplied by the official written-questions record.
11 Nov 2024
Answer published
It is critical that medicines used in the United Kingdom are safe and effective and as such, medicines cannot be marketed in the UK without a marketing authorisation. These are granted by the Medicines and Healthcare products Regulatory Agency (MHRA) whic...
Official data retrieved 27 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Dental Services: Romford
5 Nov 2024 · To ask the Secretary of State for Health and Social Care, what the average waiting time for an NHS dental practice is in Romford constituency.
Blood: Donors
11 Nov 2024 · To ask the Secretary of State for Health and Social Care, what steps he has taken to work with relevant organisations to increase blood donations in (a) England and (b) Romford constituency.
Obesity: Drugs
13 Nov 2024 · To ask the Secretary of State for Health and Social Care, what steps his Department has taken to improve the availability of GLP-1 drugs to help tackle obesity.
NHS: Standards
13 Nov 2024 · To ask the Secretary of State for Health and Social Care, what steps he his taking to use (a) data and (b) AI to improve NHS efficiency.
Prostate Cancer: Blood Tests
19 Nov 2024 · To ask the Secretary of State for Health and Social Care, if he will make it his policy to encourage the introduction of the Prostate-Specific Antigen blood test on the NHS for men (a) a strong family history of prostate cancer and (b) under 50.
Prostate Cancer: Screening
19 Nov 2024 · To ask the Secretary of State for Health and Social Care, whether his Department plans to introduce further Government advertising to encourage men to (a) speak to their GP about their risk of prostate cancer and (b) seek further testing if they are categ
Midwives: Students
19 Nov 2024 · To ask the Secretary of State for Health and Social Care, how much was spent on encouraging students to take on the career path of midwifery in the last five years.
Abortion
26 Nov 2024 · To ask the Secretary of State for Health and Social Care, whether he has taken steps to reduce the number of pregnancies terminated beyond 24 weeks.
Abortion: Drugs
26 Nov 2024 · To ask the Secretary of State for Health and Social Care, if he will commission an inquiry into the safety of taking (a) mifepristone and (b) misoprostol at home to terminate a pregnancy.
Abortion: Drugs
26 Nov 2024 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of reversing whether the decision to allow women to take (a) mifepristone and (b) misoprostol at home to terminate a pregnancy.
Drugs: Rehabilitation
3 Dec 2024 · To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce barriers to accessing drug treatment faced by women.
Drugs: Rehabilitation
3 Dec 2024 · To ask the Secretary of State for Health and Social Care, when his Department will announce future funding for drug treatment services beyond 2025.